On the other hand, TLR-7/9 antagonists such as chloroquine, hydroxy-chloroquine and quinacrine have been widely used for the treatment of immune-mediated inflammatory disorders (herein, SLE, rheumatoid arthritis, and Sjögren’s syndrome) [249]. This evidence concerns the gene TLR7 and systemic lupus erythematosus.